| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
|
JAMA
|
2005
|
4.46
|
|
2
|
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
|
Circulation
|
2005
|
2.81
|
|
3
|
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
|
J Am Coll Cardiol
|
2011
|
2.29
|
|
4
|
Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar).
|
Eur Heart J
|
2012
|
2.21
|
|
5
|
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
|
J Hypertens
|
2006
|
2.03
|
|
6
|
Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study.
|
Eur J Heart Fail
|
2014
|
1.99
|
|
7
|
Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
|
Eur J Heart Fail
|
2014
|
1.60
|
|
8
|
Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients.
|
J Heart Lung Transplant
|
2010
|
1.53
|
|
9
|
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
|
J Am Coll Cardiol
|
2009
|
1.51
|
|
10
|
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
|
J Hypertens
|
2008
|
1.45
|
|
11
|
High mortality among heart failure patients treated with antidepressants.
|
Int J Cardiol
|
2010
|
1.42
|
|
12
|
Paroxysmal atrial fibrillation is uncommon in outpatients with chronic heart failure.
|
Scand Cardiovasc J
|
2008
|
1.40
|
|
13
|
[The Mechanical Heart--HeartMate 1--Danish results].
|
Ugeskr Laeger
|
2007
|
1.40
|
|
14
|
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].
|
Ugeskr Laeger
|
2004
|
1.38
|
|
15
|
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
|
Hypertension
|
2005
|
1.31
|
|
16
|
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
|
Eur Heart J
|
2007
|
1.30
|
|
17
|
Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure.
|
Am J Physiol Regul Integr Comp Physiol
|
2005
|
1.12
|
|
18
|
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study.
|
Circulation
|
2011
|
1.06
|
|
19
|
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
|
J Card Fail
|
2004
|
1.05
|
|
20
|
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials.
|
Eur J Clin Pharmacol
|
2010
|
1.04
|
|
21
|
Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups.
|
Eur J Heart Fail
|
2011
|
1.02
|
|
22
|
Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
|
J Heart Lung Transplant
|
2009
|
1.01
|
|
23
|
Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure.
|
Eur J Heart Fail
|
2011
|
1.00
|
|
24
|
Long-term clinical variation of NT-proBNP in stable chronic heart failure patients.
|
Eur Heart J
|
2007
|
0.99
|
|
25
|
Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care.
|
Eur Heart J
|
2010
|
0.98
|
|
26
|
Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.
|
Eur J Heart Fail
|
2006
|
0.94
|
|
27
|
An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area.
|
Am Heart J
|
2002
|
0.93
|
|
28
|
Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction.
|
Eur J Heart Fail
|
2006
|
0.91
|
|
29
|
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
|
Cardiovasc Drugs Ther
|
2005
|
0.90
|
|
30
|
Kidneys extract BNP and NT-proBNP in healthy young men.
|
J Appl Physiol (1985)
|
2005
|
0.90
|
|
31
|
Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.
|
Cardiovasc Drugs Ther
|
2008
|
0.90
|
|
32
|
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study.
|
BMJ
|
2003
|
0.90
|
|
33
|
Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial.
|
Circulation
|
2013
|
0.89
|
|
34
|
Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients.
|
Clin Chem
|
2007
|
0.88
|
|
35
|
Prognostic threshold levels of NT-proBNP testing in primary care.
|
Eur Heart J
|
2008
|
0.87
|
|
36
|
Three decades of heart transplantation in Scandinavia: long-term follow-up.
|
Eur J Heart Fail
|
2012
|
0.87
|
|
37
|
Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care.
|
Eur J Heart Fail
|
2013
|
0.86
|
|
38
|
Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study).
|
Eur J Heart Fail
|
2013
|
0.85
|
|
39
|
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
|
Cardiology
|
2004
|
0.85
|
|
40
|
Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
|
Chest
|
2008
|
0.85
|
|
41
|
The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
|
Am Heart J
|
2007
|
0.84
|
|
42
|
Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction.
|
Eur J Heart Fail
|
2012
|
0.84
|
|
43
|
Effects of a nurse-based heart failure clinic on drug utilization and admissions in a community hospital setting.
|
Scand Cardiovasc J
|
2005
|
0.84
|
|
44
|
A model of physical factors in the structural adaptation of microvascular networks in normotension and hypertension.
|
Physiol Meas
|
2003
|
0.84
|
|
45
|
Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
|
Am J Cardiol
|
2012
|
0.84
|
|
46
|
Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
|
J Card Fail
|
2012
|
0.83
|
|
47
|
The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy.
|
Eur J Heart Fail
|
2009
|
0.83
|
|
48
|
Central and peripheral blood flow during exercise with a continuous-flow left ventricular assist device: constant versus increasing pump speed: a pilot study.
|
Circ Heart Fail
|
2011
|
0.81
|
|
49
|
Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure.
|
Growth Horm IGF Res
|
2009
|
0.81
|
|
50
|
Interleukin-2 receptor antagonists as induction therapy after heart transplantation: systematic review with meta-analysis of randomized trials.
|
J Heart Lung Transplant
|
2008
|
0.81
|
|
51
|
Hemodynamic stress echocardiography in patients supported with a continuous-flow left ventricular assist device.
|
JACC Cardiovasc Imaging
|
2010
|
0.81
|
|
52
|
Constrictive pericarditis in a contemporary Danish cohort: aetiology and outcome.
|
Scand Cardiovasc J
|
2015
|
0.81
|
|
53
|
Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: a long term follow-up study.
|
Int J Cardiol
|
2013
|
0.81
|
|
54
|
Local electric stimulation causes conducted calcium response in rat interlobular arteries.
|
Am J Physiol Renal Physiol
|
2002
|
0.80
|
|
55
|
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies.
|
J Heart Lung Transplant
|
2012
|
0.80
|
|
56
|
Plasma YKL-40 levels are elevated in patients with chronic heart failure.
|
Scand Cardiovasc J
|
2010
|
0.80
|
|
57
|
Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.
|
Scand Cardiovasc J
|
2011
|
0.79
|
|
58
|
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
|
Int J Cardiol
|
2006
|
0.79
|
|
59
|
Exercise-induced changes in left ventricular filling pressure after myocardial infarction assessed with simultaneous right heart catheterization and Doppler echocardiography.
|
Int J Cardiol
|
2013
|
0.79
|
|
60
|
Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure.
|
Circ Heart Fail
|
2013
|
0.79
|
|
61
|
Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF.
|
Eur J Clin Invest
|
2011
|
0.78
|
|
62
|
Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study.
|
Am Heart J
|
2008
|
0.78
|
|
63
|
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.
|
Eur J Heart Fail
|
2008
|
0.78
|
|
64
|
Wall motion index, estimated glomerular filtration rate and mortality risk in patients with heart failure or myocardial infarction: a pooled analysis of 18,010 patients.
|
Eur J Heart Fail
|
2008
|
0.78
|
|
65
|
Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure.
|
Congest Heart Fail
|
2012
|
0.78
|
|
66
|
Prevalence and characteristics of diabetic patients in a chronic heart failure population.
|
Int J Cardiol
|
2005
|
0.78
|
|
67
|
Effect of extended follow-up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study.
|
Eur J Heart Fail
|
2014
|
0.78
|
|
68
|
Prevalence and characteristics of heart failure clinics in Denmark--design of the Danish heart failure clinics network.
|
Eur J Heart Fail
|
2005
|
0.78
|
|
69
|
Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction.
|
Circ Heart Fail
|
2012
|
0.78
|
|
70
|
Relation between pressure and volume unloading during ramp testing in patients supported with a continuous-flow left ventricular assist device.
|
ASAIO J
|
2015
|
0.77
|
|
71
|
Copeptin as a biomarker in heart failure.
|
Biomark Med
|
2014
|
0.77
|
|
72
|
A high-intensity exercise program improves exercise capacity, self-perceived health, anxiety and depression in heart transplant recipients: a randomized, controlled trial.
|
J Heart Lung Transplant
|
2012
|
0.77
|
|
73
|
Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy.
|
Clin Transplant
|
2012
|
0.77
|
|
74
|
Interval training does not modulate diastolic function in heart transplant recipients.
|
Scand Cardiovasc J
|
2014
|
0.77
|
|
75
|
"Sausage-string" appearance of arteries and arterioles can be caused by an instability of the blood vessel wall.
|
Am J Physiol Regul Integr Comp Physiol
|
2002
|
0.77
|
|
76
|
Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.
|
Int J Cardiol
|
2006
|
0.77
|
|
77
|
Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosis.
|
Acta Haematol
|
2014
|
0.76
|
|
78
|
Good long-term survival after paediatric heart transplantation.
|
Dan Med J
|
2012
|
0.76
|
|
79
|
Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 years.
|
BMC Cardiovasc Disord
|
2011
|
0.76
|
|
80
|
Hereditary hemochromatosis (HFE) genotypes in heart failure: relation to etiology and prognosis.
|
BMC Med Genet
|
2010
|
0.76
|
|
81
|
Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
|
Am J Cardiol
|
2007
|
0.75
|
|
82
|
Immunosuppressive T-cell antibody induction for heart transplant recipients.
|
Cochrane Database Syst Rev
|
2013
|
0.75
|
|
83
|
Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: a 7-year follow-up study.
|
BMC Nephrol
|
2013
|
0.75
|
|
84
|
Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients.
|
J Heart Lung Transplant
|
2009
|
0.75
|
|
85
|
Characteristics and outcome of patients with heart failure due to anabolic-androgenic steroids.
|
Scand Cardiovasc J
|
2014
|
0.75
|
|
86
|
Right ventricular failure after implantation of a continuous-flow left ventricular assist device: early haemodynamic predictors.
|
Eur J Cardiothorac Surg
|
2013
|
0.75
|
|
87
|
Sildenafil and diastolic dysfunction after acute myocardial infarction trial: rationale and design.
|
Clin Cardiol
|
2013
|
0.75
|
|
88
|
[Destination therapy in end-stage heart failure. A possible alternative to heart transplantation?].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
89
|
Creating interatrial shunts in heart failure and pulmonary hypertension.
|
EuroIntervention
|
2016
|
0.75
|
|
90
|
Elevated heart rate is also a risk factor after cardiac transplantation: time to slow down?
|
Int J Cardiol
|
2013
|
0.75
|
|
91
|
Ramp Study Hemodynamics, Functional Capacity, and Outcome in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices.
|
ASAIO J
|
2016
|
0.75
|
|
92
|
[MR-skanning af kardial amyloidose].
|
Ugeskr Laeger
|
2015
|
0.75
|
|
93
|
Use of quinine and mortality-risk in patients with heart failure--a Danish nationwide observational study.
|
Pharmacoepidemiol Drug Saf
|
2015
|
0.75
|
|
94
|
Effect of Calcineurin Inhibitor-Free Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate after Heart Transplantation.
|
Transplantation
|
2017
|
0.75
|
|
95
|
Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?
|
J Hypertens
|
2017
|
0.75
|
|
96
|
Efficacy and safety of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia.
|
J Card Fail
|
2013
|
0.75
|
|
97
|
Bisoprolol for congestive heart failure.
|
Expert Opin Pharmacother
|
2008
|
0.75
|
|
98
|
[Establishment of a nurse-led heart failure clinic. Design and baseline data from the first two years].
|
Ugeskr Laeger
|
2003
|
0.75
|